Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/25/2025

Post-Thoracentesis Cough Management

Introduction to Ipratropium Plus Salbutamol

  • The British Thoracic Society recommends ipratropium plus salbutamol for acute asthma exacerbations and severe COPD exacerbations, but not for post-thoracentesis cough 1

Evidence-Based Alternatives for Post-Thoracentesis Cough

  • For severe non-productive cough, guidelines suggest nebulized local anesthetics such as lignocaine 2% or bupivacaine 0.25%, repeated up to four hourly, preceded by a beta-agonist given by hand-held inhaler 1

Appropriate Use of Ipratropium-Salbutamol

  • The combination of salbutamol and ipratropium should be reserved for COPD exacerbations, with a dosage of salbutamol 2.5-5 mg with ipratropium 250-500 μg nebulized every 4-6 hours in moderate-to-severe cases 1
  • Ipratropium plus salbutamol is indicated for acute severe asthma when patients show poor response to beta-agonist alone, particularly with PEF <50% predicted 1
  • Ipratropium alone may attenuate postinfectious cough when bronchial hyperresponsiveness is present 2

Critical Assessment and Pitfalls

  • Post-thoracentesis cough requires assessment for re-expansion pulmonary edema 1
  • Post-thoracentesis cough requires assessment for pneumothorax 2
  • Post-thoracentesis cough requires assessment for pleural irritation 1
  • Post-thoracentesis cough requires assessment for underlying lung pathology 2